Matsui, Takanori <br/><br/>
Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis.  [electronic resource] 

 -  Pharmacological research  May 2011 
 - 383-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-1186 
<br/><br/><label>Standard No.: </label>10.1016/j.phrs.2011.02.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adamantane--analogs & derivatives<br/>Animals<br/>Aorta, Thoracic--drug effects<br/>Diabetes Mellitus, Type 2--complications<br/>Dipeptidyl-Peptidase IV Inhibitors--pharmacology<br/>Glycation End Products, Advanced--metabolism<br/>Male<br/>Nitriles--pharmacology<br/>Obesity--complications<br/>Pyrrolidines--pharmacology<br/>Rats<br/>Rats, Inbred OLETF<br/>Vascular System Injuries--drug therapy<br/>Vildagliptin